CHRSCoherus Oncology, Inc.$1.24-2.36%
WAIT.
A falling knife — never catch it mid-drop.
The stock is still dropping hard on heavy volume with no support underneath. 4 of 4 entry triggers may be firing, but a live slide overrides them — that is exactly the setup this check exists for. It does not call the bottom; it says the drop is not finished.
QTick signal
+1net
1 bull / 0 bear factors · balancedBull 2 pts·Bear 1 pts30d
4 of 4 aligned — not yet
A falling knife — the guard overrides the entry triggers.
Market context—Sector read · not on file—Balance sheet · not on file—PCE sensitivity · not on fileRiskFalling-knife phase · 89/100 · was 58 on Aug 60/6Bottom watch · 0 of 6 confirmations
Chart pattern
Death cross
50d below 200d · bearish structure
Volume vs 20-day avg0.90× · 967.1K vs 1.08M avg
52-week range$0.83 – $2.62
Below high since 2015-96.7% · $37.73 high
Risk / reward—
Plan stop—
Max pain—
RSI 1434.4 washed out
Forensic flags2 review
What-if price
$1.24
$1.05 · -15.4%-15.4%move the price to stress-test the setupdrag to test another price+15.4% · $1.43+15.4%
Entry strategy · 10 triggers4 of 4 aligned — not yet
RSI 14✓
34.4
washed out
vs 50-day✓
$1.45
below the line
Bollinger✓
$1.27
lower-band pierce
VWAP 20✓
$1.38
below the rolling VWAP
Entry level●
—
not on file
Put wall●
—
not on file
MACD●
-0.02
below zero · still falling
RVolStatic
0.90×
below the 1.5× context threshold
Short int.Static
16.0%
short interest below 20%
ATRStatic
$0.10
14-session average true range
A checklist, not odds on a return: 3 of 4 usable price conditions have to line up. RSI, the 50-day average and the Bollinger band move with the price you set; the 20-day average traded price, the entry level and the busiest put strike stay fixed. MACD, relative volume and short interest are context only — they never count toward the total.
Next earnings
5 Nov 2026 · after the bell
amc · in 86 days
Next dividend
No indicated yield
no forward dividend on file